Skip to main content

Find a Clinical Trial

Filter

Services
Showing 1 - 10 out of 12
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
medical-cross
Bladder cancer
user
All genders
person-wave 18+
world
Recruiting now
info
Department of Medicine, Cancer Center
Learn more
AbbVie ELASCI
medical-cross
Spine injuries and disorders
user
All genders
person-wave 18-70
world
Recruiting now
info
Department of Neurology
Learn more
Assist
medical-cross
Chronic kidney disease
user
All genders
person-wave 18+
world
Recruiting now
info
Department of Medicine, Division of Nephrology
Learn more
VX19-NEN-801
medical-cross
Chronic kidney disease, Glomerular disease, Kidney diseases, Proteinuria
user
All genders
person-wave 12-65
world
Recruiting now
info
Department of Medicine, Division of Nephrology
Learn more
AMPLITUDE
medical-cross
Chronic kidney disease, Nephropathy, Proteinuria
user
All genders
person-wave 18-65
world
Recruiting now
info
Department of Medicine, Division of Nephrology
Learn more
CKD Registry
medical-cross
Chronic kidney disease
user
All genders
person-wave 18-100
world
Recruiting now
info
Department of Medicine, Division of Nephrology
Learn more
Cognitive Impairment in HD patients
medical-cross
Hemodialysis access
user
All genders
person-wave 18+
world
Recruiting now
info
Department of Medicine, Division of Nephrology
Learn more
Jump back to top